4//SEC Filing
Thompson Tamar 4
Accession 0001161697-23-000617
CIK 0001369568other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 5:00 PM ET
Size
8.0 KB
Accession
0001161697-23-000617
Insider Transaction Report
Form 4
Thompson Tamar
Director
Transactions
- Award
Options to purchase common stock
2023-12-08+29,524→ 69,524 totalExercise: $14.15Exp: 2030-12-08→ Common Stock (29,524 underlying) - Award
Restricted Stock Units
2023-12-08+4,240→ 73,764 total→ Common Stock (4,240 underlying)
Footnotes (3)
- [F1]Derivative securities vest in equal tranches, 1/3rd on December 8, 2024, 1/3rd on December 8, 2025 and 1/3rd on December 8, 2026.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
- [F3]Shares of common stock will be delivered to the Reporting Person upon vesting.
Documents
Issuer
CATALYST PHARMACEUTICALS, INC.
CIK 0001369568
Entity typeother
Related Parties
1- filerCIK 0001839248
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 5:00 PM ET
- Size
- 8.0 KB